Treating the root cause of the pain. Not the symptoms.

Instead of costly procedures, such as spinal fusion or long-term physiotherapy, our cLBP treatment is an easily performed, single injection procedure that stabilizes the disk by transforming it to connective tissue. Unlike any other currently available treatment this has the potential to permanently remove or reduce the pain significantly faster than surgical intervention.

Healthy disc

An intervertebral disc consists of two main parts: the disc centre and the wall. The disc centre consists largely of a highly hydrated gel together with nucleus pulposus cells and fibroblasts.

DEGENERATED, UNTREATED DISC

When a disc degenerates it becomes less stable and pro-inflammatory substances formed during the degenerative process can leak from the inner core of the disc. Pain-sensing nerves within and outside the wall of the disc are activated. These processes cause back pain.

Treated disc

By injecting a biologically active substance directly into the degenerated intervertebral disc, the cells are triggered to produce collagen and transform the damaged disc into connective tissue. This helps re-stabilize the intervertebral segment and reduces diffusion of pro-inflammatory substances.

Market outlook: 5 million treatable patients only in the US

We are currently taking the next step in our exciting journey towards an injection-based treatment for chronic low back pain. With our STA-363 treatment undergoing clinical phase 1b, we are one step closer to market.

Our market

LET’S MEET UP

We are participating in several conferences and industry event every year. Please do not hesitate to contact us to meet up.

Coming events
1 July 2018

Meet Stayble at Park Annual in Gothenburg

Meet Stayble at Park annual on the 27th of September.

Read more
29 June 2018

Meet Stayble at NLSDAYS in stockholm

Stayble will attend NLSDays in Stockholm in 10-12 of September. We will be pitching at the Startup Challenge, read more at https://www.nlsdays.com/program/startup-challenge/. Our main focus at the event is early…

Read more

Latest news

Stay updated on our development journey

news
29 June 2018

Approved SME Instruments Phase I application

Stayble is happy to announce that our SME Instrument phase I application has been approved by the EU commission with a score of 14,51 out of 15.    

Read more
12 June 2018

Stayble welcomes Jane Buus Laursen to the Board of directors

Stayble is happy to announce that our board will be strengthen by Jane Buus Laursen. Read more about her under “Our Team”. 

Read more

Get in touch

We are always looking for passionate people who are interested in joining us to help realizing our vision. Please leave your contact details and we will get back to you shortly.